Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Protagonist and Janssen select new oral peptide IL-23 receptor antagonist candidates

Nov. 3, 2020

bit.bio and London Institute for Mathematical Sciences partner on production of human cells

Oct. 23, 2020

Ideaya and the Broad Institute partner to advance synthetic lethality programs

Oct. 23, 2020

Albumin transports proteins across mucosa, into lymph nodes

Oct. 19, 2020

Fujitsu and PeptiDream announce milestone under joint research effort

Oct. 14, 2020

Three's a crowd: Doudna-Charpentier duo is sole winner of chemistry Nobel

Oct. 8, 2020

Intellia presents preclinical data on CRISPR/Cas9 platform

Oct. 1, 2020

Sudoku-solving algorithm predicts protein structure, too

Sep. 29, 2020

CRISPR immune suppression strengthens CRISPR gene therapy

Sep. 8, 2020

Neurotransmitter-derived synthetic lipids for delivery of BBB-impermeable cargos into the brain

Aug. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...